Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cyclooxygenase (COX) pathway is a major metabolic route responsible for converting arachidonic acid into prostanoids (prostaglandins, prostacyclins, and thromboxanes), which play critical roles in inflammation, hemostasis, renal function, and other physiological processes. The central enzymes are cyclooxygenases (COXs), with two main isoforms: COX-1 (constitutive) and COX-2 (inducible). Inhibition of this pathway is a common therapeutic strategy for managing pain and inflammation.
Inhibition of cyclooxygenase enzymes (COX-1 and/or COX-2), leading to reduced prostanoid synthesis.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cyclooxygenase pathway.